Angiotensin AT1 Receptors and Their Ligands (Review)
- Авторлар: Spasov A.A.1,2, Yakovlev D.S.1,2, Brigadirova A.A.1,2
- 
							Мекемелер: 
							- Volgograd State Medical University
- Volgograd Medical Scientific Center
 
- Шығарылым: Том 51, № 1 (2017)
- Беттер: 1-8
- Бөлім: Molecular Biological Problems of Drug Design and Mechanism of Drug Action
- URL: https://ogarev-online.ru/0091-150X/article/view/244493
- DOI: https://doi.org/10.1007/s11094-017-1546-y
- ID: 244493
Дәйексөз келтіру
Аннотация
This review addresses on the most intensely studied biological targets in the body – type 1 angiotensin receptors. Particular attention is focused on receptor structure and its interaction with various intracellular signal molecules. Data on long-known and newly created ligands able to influence AT1 receptors are presented. The individual structural fragments of AT1 antagonist molecules with functional significance for this type of activity are described. The review includes a brief analysis of the potentials for the clinical use of AT1 antagonists in a number of pathological states additional to the registered indications, including arterial hypertension, chronic heart failure, and nephropathy in type 2 diabetes mellitus. These results from the discovery of additional aspects of the mechanism of action of antagonists and their ability to produce effects such as neuroprotective and anti-inflammatory actions, as well as various organ-protective properties.
Негізгі сөздер
Авторлар туралы
A. Spasov
Volgograd State Medical University; Volgograd Medical Scientific Center
														Email: DYPharm@list.ru
				                					                																			                												                	Ресей, 							Volgograd; Volgograd						
D. Yakovlev
Volgograd State Medical University; Volgograd Medical Scientific Center
							Хат алмасуға жауапты Автор.
							Email: DYPharm@list.ru
				                					                																			                												                	Ресей, 							Volgograd; Volgograd						
A. Brigadirova
Volgograd State Medical University; Volgograd Medical Scientific Center
														Email: DYPharm@list.ru
				                					                																			                												                	Ресей, 							Volgograd; Volgograd						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					